immune checkpoint inhibitor

You have access
Hyperthermia Enhances the Effects of ICI by Increasing PD-L1 Expression Through Induction of CD8⁺ Cell Infiltration
NAOTSUGU HARAGUCHI, YUHKI YOKOYAMA, YUI KUBOTA, SHIHORI KOUDA, HIROYUKI YAMAMOTO, SATOSHI SHIBATA, HIROKO TAKEDA, HIROFUMI YAMAMOTO and TSUTOMU TAKEDA

Anticancer Research October 2026, 46 (10) 5399-5410; DOI: https://doi.org/10.21873/anticanres.18385
You have access
Pembrolizumab plus Chemotherapy for Synchronous Multiple Primary Esophageal and Gingival Squamous Cell Carcinomas
HOTAKA TAMURA, YUKIKO OTSUKI and AYUMU HOSOKAWA

Anticancer Research October 2026, 46 (10) 5759-5766; DOI: https://doi.org/10.21873/anticanres.18418
You have access
Early LMR Dynamics and AFP Status in Advanced HCC Treated With Atezolizumab/Bevacizumab
MASAKI OMORI, SHOHEI KOMATSU, TOSHIFUMI TADA, NOBUAKI ISHIHARA, TAKANORI MATSUURA, EISUKE UESHIMA, YOSHIMI FUJISHIMA, JUN ISHIDA, MASAHIRO KIDO, HIDETOSHI GON, KENJI FUKUSHIMA, TAKESHI URADE, HIROAKI YANAGIMOTO, KEITARO SOFUE, YUZO KODAMA and TAKUMI FUKUMOTO

Anticancer Research September 2026, 46 (9) 5119-5127; DOI: https://doi.org/10.21873/anticanres.18358
You have access
Development of a Prognostic Model for Patients Aged ≤65 Years With Metastatic Renal Cell Carcinoma
YUYA OISHI, YUTO MATSUSHITA, SHINYA WATANABE, KYOHEI WATANABE, HIROMITSU WATANABE, KEITA TAMURA, DAISUKE MOTOYAMA, TAKAFUMI YANAGISAWA, KEIICHIRO MORI, SEITETSU SUGIYAMA, KENSUKE BEKKU, SHINGO TOYODA, TAKUHISA NUKAYA, RYOICHI MAENOSONO, KAZUMASA KOMURA, MOTOO ARAKI, KAZUTOSHI FUJITA, KIYOSHI TAKAHARA, HARUHITO AZUMA, TERUO INAMOTO and JK-FOOT STUDY GROUP

Anticancer Research June 2026, 46 (6) 3293-3302; DOI: https://doi.org/10.21873/anticanres.18198
You have access
Pembrolizumab and Quality of Life in Recurrent or Metastatic Head and Neck Cancer
KOUSUKE HIHARA, ISAKU OKAMOTO, KUNIHIKO TOKASHIKI, YURI UEDA, KENJI HANYU and KIYOAKI TSUKAHARA

Anticancer Research June 2026, 46 (6) 3343-3350; DOI: https://doi.org/10.21873/anticanres.18202
Open Access
Metabolism-driven Immune Escape Defines Therapeutic Vulnerability in Type I and Type II Ovarian Cancer
KOHEI MIYATA and FUSANORI YOTSUMOTO

Anticancer Research May 2026, 46 (5) 2851-2861; DOI: https://doi.org/10.21873/anticanres.18164
Open Access
SLFN11 Drives GM-CSF–mediated M1 Macrophage Polarization and Enhances Immunotherapy Response in Renal Cell Carcinoma
YOHEI OKUDA, JUNKO MURAI, TSUYOSHI TAKASHIMA, NAOYA SAKAMOTO, AKIHIRO YOSHIMURA, MASARU TANI, YUKI HORIBE, YUTONG LIU, NESRINE SASSI, TOSHIKI OKA, TOSHIHIRO UEMURA, AKINARU YAMAMOTO, GAKU YAMAMICHI, YU ISHIZUYA, TAKUJI HAYASHI, YOSHIYUKI YAMAMOTO, KOJI HATANO, ATSUNARI KAWASHIMA, EIICHI MORII, NORIO NONOMURA and TAIGO KATO

Anticancer Research March 2026, 46 (3) 1213-1234; DOI: https://doi.org/10.21873/anticanres.18024
You have access
Efficacy of Second-line Lenvatinib for Hepatocellular Carcinoma After Early Progression on Atezolizumab–Bevacizumab
HISANORI MUTO, TEIJI KUZUYA, YOSHIHIKO TACHI, YOSUKE NAGANO, YUTARO KAJINO, MISAE MATSUSHITA, SEIYA HAGIHARA, SATOSHI YAMAMOTO, TAKASHI KOBAYASHI, YOSHIAKI KATANO, NAOKI OHMIYA, SENJU HASHIMOTO, MIZUKI ARIGA, SAYAKA MORISAKI, GAKUSHI KOMURA, TAKUJI NAKANO, HIROYUKI TANAKA, KAZUNORI NAKAOKA, EIZABURO OHNO, KOHEI FUNASAKA, MITSUO NAGASAKA, RYOJI MIYAHARA and YOSHIKI HIROOKA

Anticancer Research March 2026, 46 (3) 1609-1618; DOI: https://doi.org/10.21873/anticanres.18056
Open Access
Neck Dissection and Immune Checkpoint Inhibitor Efficacy in Head and Neck Cancer: A Retrospective Study
YOH-ICHIRO IWASA, KENTARO HORI, YOH YOKOTA, RYOSUKE KITOH, SHINTARO YAMAZAKI, TAKUYA OKUBO and YUTAKA TAKUMI

Anticancer Research February 2026, 46 (2) 1079-1087; DOI: https://doi.org/10.21873/anticanres.18010
You have access
Prognostic Factors in Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
YUTAKA TAKAHARA, RYUDAI ABE, SUMITO NAGAE, TAKUYA TANAKA, YOKO ISHIGE, IKUYO SHIONOYA, KOUICHI YAMAMURA, MASAFUMI NOJIRI and MASAHARU IGUCHI

Anticancer Research December 2025, 45 (12) 5633-5644; DOI: https://doi.org/10.21873/anticanres.17897

Main menu

User menu

Search

immune checkpoint inhibitor

Pages